risks of glp-1 Long-Term Effects Medications: What You Should Know GLP-1 Muscle Loss Explained |
Description
Giorgino F, Penfornis A, Pechtner V, Gentilella R, Corcos A
doi: 10.1111/ane.12793
Critical Reviews in Food Science and Nutrition, 64 (10), 31393150
Assessed by a meal tolerance test after treatment, RG7697 dose-dependently reduced maximal plasma glucose and insulin concentrations by up to ~50% compared to a meal tolerance test at baseline [125]
Mean change in body weight from baseline to Week 52 was a secondary endpoint
Neuropharmacology (2014) 84:3145
